Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/01/2005US20050266526 Glycoprotein synthesis
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266522 Human amine receptor
12/01/2005US20050266520 Process for the synthesis of peptides
12/01/2005US20050266519 Methods and compositions for modulating and detecting activin dimer and dimer formation
12/01/2005US20050266498 Method for screening biomolecule activity regulator
12/01/2005US20050266493 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
12/01/2005US20050266491 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent and the use thereof in diagnostics, high throughput screening and novelty items
12/01/2005US20050266490 Using membrane protein as tool in identifying modulators for prevention and treatment of cell proliferative, autoimmune, inflammatory, nervous system and metabolic disorders
12/01/2005US20050266488 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria
12/01/2005US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
12/01/2005US20050266482 Regulation of human CYSLT2-like GPCR protein
12/01/2005US20050266480 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266477 Reagents and methods useful for detecting diseases of the gastrointestinal tract
12/01/2005US20050266471 Common marmoset-derived beta-actin gene and use thereof
12/01/2005US20050266470 25501, a human transferase family member and uses therefor
12/01/2005US20050266465 Interferon-alpha polypeptides and conjugates
12/01/2005US20050266464 C1q family member proteins with altered immunogenicity
12/01/2005US20050266463 introducing into plant cell comprising gene of interest a polynucleotide encoding human PMS2-134 or Arabidopsis PMS2-134 proteins, where polynucleotide has termination codon at codon 134 or after codons 1-147, which when expressed forms truncated PMS2 protein, cell becomes hypermutable, testing cell
12/01/2005US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/01/2005US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/01/2005US20050266445 Purified mammalian CTLA-8 antigens and related reagents
12/01/2005US20050266443 Novel tumor suppressor gene and compositions and methods for making and using the same
12/01/2005US20050266440 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants
12/01/2005US20050266439 Thermostable RNA ligase from thermus phage
12/01/2005US20050266435 VR1 receptors and uses thereof
12/01/2005US20050266431 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
12/01/2005US20050266430 A mutated G-CSF mRNA or cDNA fragment having a deletion of an exon 3 region for use; primer for use in amplification of a G-CSF gene
12/01/2005US20050266426 Confluence regulated adhesion molecules useful in modulating vascular permeability
12/01/2005US20050266423 Novel nucleic acids and polypeptides
12/01/2005US20050266421 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/01/2005US20050266416 Molecular nanomotor
12/01/2005US20050266406 Maxs as modifiers of the axin pathway and methods of use
12/01/2005US20050266400 Novel sequences encoding hepatitis C virus glycoproteins
12/01/2005US20050266399 HCV regulated protein expression
12/01/2005US20050266093 Nanogene therapy for cell proliferation disorders
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050266029 with botulinum toxin
12/01/2005US20050266026 Multi plasmid system for the production of influenza virus
12/01/2005US20050266025 Novel use
12/01/2005US20050266024 Adjuvant
12/01/2005US20050266023 Generation of virus-like particles and use as panfilovirus vaccine
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266019 Infectious bursal disease virus antigenic isolates and vaccines
12/01/2005US20050266017 Plasmodium falciparum antigens inducing protective antibodies
12/01/2005US20050266016 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
12/01/2005US20050266014 Tumor antigen based on products of the tumor suppressor gene WT1
12/01/2005US20050266013 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood
12/01/2005US20050265995 Tissue targeted complement modulators
12/01/2005US20050265992 cell adhesion molecule determined to effect platelet aggregation, secretion, platelet spreading and cellular adhesion; thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation
12/01/2005US20050265989 Non-toxic purification and activation of prothrombin and use thereof
12/01/2005US20050265975 Method for selective inactivation of viral replication
12/01/2005US20050265974 Recombinant viral-based malaria vaccines
12/01/2005US20050265972 A genetic construct containing a glucose inducible regulatory element with a pair of CACGTG nucleotide sequences and confer human proinsulin expression in host hepatocyte cells; therapy for diabetes
12/01/2005US20050265970 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis
12/01/2005US20050265969 Therapeutic chemokine receptor antagonists
12/01/2005US20050265967 Interferon-alpha induced gene
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005US20050265924 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
12/01/2005US20050265921 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
12/01/2005DE102004023187A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy
12/01/2005DE102004017141A1 Neue Gene aus Biosynthese Genclustern zur Synthese von Aminoglycosid-Antibiotika sowie damit herstellbare neue Aminoglycosid-Antibiotika New genes from biosynthesis gene clusters for the synthesis of aminoglycoside antibiotics and thus producible new aminoglycoside antibiotics
12/01/2005CA2797972A1 Maize multidrug resistance-associated protein polynucleotides and methods of use
12/01/2005CA2572446A1 Combinatorial selection of phosphorothioate aptamers for tgf-beta
12/01/2005CA2569272A1 Promotion of somatic embryogenesis in plants by pga37 gene expression
12/01/2005CA2568248A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
12/01/2005CA2567650A1 A probe for detection and quantification of inositol-1,4,5-trisphosphateand a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same
12/01/2005CA2567635A1 Selective vpac2 receptor peptide agonists
12/01/2005CA2567501A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005CA2567496A1 C1q family member proteins with altered immunogenicity
12/01/2005CA2567366A1 Methods for production of xylitol in microorganisms
12/01/2005CA2567330A1 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1)
12/01/2005CA2567272A1 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
12/01/2005CA2566949A1 Polynucleotides for the detection of escherichia coli o157:h7 and escherichia coli o157:nm verotoxin producers
12/01/2005CA2566925A1 Genotoxic testing
12/01/2005CA2566903A1 Modified antigen-presenting cells
12/01/2005CA2566725A1 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
12/01/2005CA2566439A1 Methods of preventing and treating alimentary mucositis
12/01/2005CA2566363A1 High affinity ny-eso t cell receptor
12/01/2005CA2566247A1 Interferon-alpha polypeptides and conjugates
12/01/2005CA2565974A1 Cell surface receptor isoforms and methods of identifying and using the same
12/01/2005CA2565804A1 Haplotype markers and methods of using the same to determine response to treatment
12/01/2005CA2565300A1 Fgf-21 fusion proteins
12/01/2005CA2565014A1 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
12/01/2005CA2564770A1 Chimeric soluble hyper il-11 and use thereof
12/01/2005CA2564740A1 Selective vpac2 receptor peptide agonists
12/01/2005CA2564584A1 Hdm2-inhibitor complexes and uses thereof
12/01/2005CA2563666A1 Differentially expressed claudin-18 variants in tumors and use thereof
12/01/2005CA2562482A1 Novel gene disruptions, compositions and methods relating thereto
12/01/2005CA2557053A1 Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/2005
11/30/2005EP1600511A1 Method of treating ischemic disease
11/30/2005EP1600510A2 DNA sequences having anti-repressor activity
11/30/2005EP1600507A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
11/30/2005EP1600458A1 Novel gene relating to fibrotic conditions
11/30/2005EP1600456A1 Method for the purification of polymers carrying a lipophilic group
11/30/2005EP1600455A1 Preparation of solid phase bound peptides or PNAs
1 ... 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 ... 2916